# A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of PRV-3279 in Healthy Subjects

> **NCT03955666** · PHASE1 · COMPLETED · sponsor: **Provention Bio, Inc.** · enrollment: 16 (actual)

## Conditions studied

- Safety

## Interventions

- **BIOLOGICAL:** PRV-3279 or placebo

## Key facts

- **NCT ID:** NCT03955666
- **Lead sponsor:** Provention Bio, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-07
- **Primary completion:** 2019-12-11
- **Final completion:** 2019-12-11
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2023-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03955666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03955666, "A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of PRV-3279 in Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03955666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*